# Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer

> **NCT05764044** · PHASE3 · RECRUITING · sponsor: **Hospital do Coracao** · enrollment: 365 (estimated)

## Conditions studied

- Cervical Cancer
- Cervix Cancer
- Cervix Neoplasm

## Interventions

- **DRUG:** cisplatin, gemcitabine
- **OTHER:** Follow-up

## Key facts

- **NCT ID:** NCT05764044
- **Lead sponsor:** Hospital do Coracao
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-27
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 365 (ESTIMATED)
- **Last updated:** 2024-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05764044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05764044, "Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05764044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*